GUARNERI, PATRIZIA
GUARNERI, PATRIZIA
Istituto di Farmacologia Traslazionale - IFT - Sede Secondaria Palermo
CRISPR/Cas9 "CLN8 null" towards a dysfunctional autophagy in CLN8-associated neuronal ceroid lipofuscinosis diseases-ePoster # 4774
2020 Guarneri, P; Saladino, P; Tinnirello, R; Cernigliaro, C; Papasergi, S
Riunione Annuale CLNet
2019 Guarneri, Patrizia
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. II Report
2019 Salvatore Papasergi; Patrizia Saladino; Rosaria Tinnirello; Cesare Cernigliaro; Simona Prioni; Sara Grassi; Laura Mauri; Paola Giussani; Alessandro Prinetti; Patrizia Guarneri
La patogenesi delle varianti CLN8 nelle ceroidolipofuscinosi.
2017 Patrizia Guarneri
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
2017 Blanco, Ar; Bondi, Ml; Cavallaro, G; Consoli, Gml; Craparo, Ef; Giammona, G; Licciardi, M; Pitarresi, G; Granata, G; Saladino, P; La Marca, C; Deidda, I; Papasergi, S; Guarneri, P; Cuzzucrea, S; Esposito, E; Viola, S
Orphanet - Il portale delle malattie rare e dei farmaci orfani: Biological and genetic variables in the pathogenesis and clinical progression of amyotrophic lateral sclerosis: identification of biomarkers .
2017 Guarneri P.
Orphanet - Il portale delle malattie rare e dei farmaci orfani: The CLN8 variant late-infantile neuronal ceroid lipofuscinosis (CLN8-vLINCL): functional aspects of the CLN8 protein and characterization of the degenerative mechanisms .
2017 Guarneri, P
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with Vesicle-Associated Membrane Protein-associated Protein A (VAPA), and genotype-phenotype correlations
2017 Patrizia Guarneri
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. TELETHON Grant GGP16277
2017 Guarneri, Patrizia; Papasergi, Salvatore; Saladino, Patrizia; Deidda, Irene; Prinetti, Alessandro
Eye drops of Ch-Cx carrier silibinin inducing protection in a model of Age-related Macular Disease (AMD).
2016 La Marca C.; Deidda I.; Saladino P.; Papasergi S.; Pinto P.; Granata G.; Geraci C.; Consoli G. M. L.; Blanco A. R.; Guarneri P..
Formulations used to treat ocular diseases comprising e.g. macular edema, uveitis, comprise active ingredients incorporated in nanostructured systems
2016 Blanco, Ar; Bondi', Ml; Cavallaro, G; Consoli, Mgl; Craparo, Ef; Cuzzocrea, S; Deidda, I; Esposito, E; Giammona, G; Granata, G; Guarneri, P; LA MARCA, C; Licciardi, M; Pasergi, S; Pitarresi, G; Saladino, P; Viola, S
Interaction of alphaA-crystallin with beta-amyloid in diabetic retina: an emerging antifibrillogenesis activity.
2016 R Marabeti, Maria; Cascio, Caterina; Russo, Domenica; Guarneri, Patrizia
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect
2016 Cannava', C; Stancanelli, R; Marabeti, M R; Venuti, V; Cascio, C; Guarneri, P; Bongiorno, C; Sortino, G; Majolino, D; Mazzaglia, A; Tommasini, S; Ventura, C A
Neglected CLN8 protein function in the neuronal ceroid lipofuscinoses (NCLs).
2016 Patrizia Saladino; Salvatore Papasergi; Irene Deidda; Patrizia Guarneri.
Studi di biodisponibilità della Silibinina strutturata in nanoparticelle per la terapia di patologie retiniche neurodegenerative
2016 Pinto, P; Guarneri, P
Tackling mechanisms of CLN8 mutations in neuronal ceroid lipofuscinosis (NCLs).
2016 Patrizia Saladino; Salvatore Papasergi; Irene Deidda; Patrizia Guarneri
Topical application of choline-calix[4]arene nanocarrier of silibinin reduces retinal damage in a model of Age-Related Macular Disease.
2016 La Marca, C; Deidda, I; Saladino, P; Papasergi, S; Pinto, P; Granata, G; Geraci, C; Consoli, G M L; Blanco, A R; Guarneri, P
A bicistronic vector to study the effect of CLN8/VAPA interaction on cell physiology and eventually the pathology of CLN8-associated NLC diseases
2015 S. Papasergi; P. Saladino; I. Deidda; D. Russo; P. Guarneri.
CLN8 protein: a post-translation modification and subcellular distribution study for understanding CLN8 physiopathology
2015 Saladino, P; Papasergi, S; Deidda, I; Russo, D; Guarneri, P
HIPPOCRATES PON02_00355 Regione Sicilia - Sviluppo di Micro e Nano-Tecnologie e Sistemi Avanzati per la Salute dell'uomo.
2015 Guarneri, Patrizia; Saladino, Patrizia; Rita Blanco, Anna